MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 100 filers reported holding MYOVANT SCIENCES LTD in Q3 2022. The put-call ratio across all filers is 1.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,542,544 | +580.0% | 131,400 | +352.7% | 0.01% | +450.0% |
| Q3 2022 | $521,000 | +129.5% | 29,026 | +70.5% | 0.00% | +100.0% |
| Q1 2022 | $227,000 | -77.6% | 17,022 | -62.3% | 0.00% | -50.0% |
| Q3 2021 | $1,013,000 | +33.1% | 45,136 | +22.0% | 0.00% | 0.0% |
| Q1 2021 | $761,000 | +3.3% | 36,997 | +38.7% | 0.00% | 0.0% |
| Q4 2020 | $737,000 | +120.0% | 26,668 | +12.0% | 0.00% | +100.0% |
| Q3 2020 | $335,000 | -89.5% | 23,816 | -84.7% | 0.00% | -93.8% |
| Q2 2020 | $3,202,000 | +102.9% | 155,266 | -25.7% | 0.02% | +23.1% |
| Q1 2020 | $1,578,000 | +77.3% | 208,976 | +264.4% | 0.01% | +333.3% |
| Q4 2019 | $890,000 | +153.6% | 57,343 | -15.0% | 0.00% | +200.0% |
| Q3 2019 | $351,000 | -35.4% | 67,473 | +12.5% | 0.00% | -50.0% |
| Q2 2019 | $543,000 | +168.8% | 60,000 | +690.2% | 0.00% | +100.0% |
| Q3 2018 | $202,000 | – | 7,593 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 3,474,645 | $71,647,000 | 83.05% |
| VR Adviser, LLC | 845,000 | $17,424,000 | 4.17% |
| Opaleye Management Inc. | 682,500 | $14,073,000 | 2.84% |
| Eversept Partners, LP | 760,551 | $15,682,562 | 2.15% |
| Cormorant Asset Management, LP | 2,500,000 | $51,550,000 | 1.97% |
| Ghost Tree Capital, LLC | 300,000 | $6,186,000 | 1.63% |
| Bellevue Group AG | 4,647,000 | $95,821,000 | 1.36% |
| Aristides Capital LLC | 67,000 | $1,382,000 | 1.04% |
| Amia Capital LLP | 27,070 | $558,000 | 0.46% |
| Rhenman & Partners Asset Management AB | 150,000 | $3,093,000 | 0.33% |